Engineers Gate Manager LP Amgen Inc Transaction History

Engineers Gate Manager LP

$4.27 Billion
Q2 2024

A detailed history of Engineers Gate Manager LP transactions in Amgen Inc stock. As of the latest transaction made, Engineers Gate Manager LP holds 10,947 shares of AMGN stock, worth $3.53 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

10,947

Previous 8,055 35.9%

Holding current value

$3.53 Million

Previous $2.29 Million 49.34%

% of portfolio

0.08%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $759,873 - $923,444	2,892 Added 35.9%	10,947 $3.42 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $841,563 - $1.02 Million	-3,130 Reduced 27.98%	8,055 $2.29 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $2.86 Million - $3.23 Million	11,185 New	11,185 $3.22 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $209,984 - $248,302	980 Added 65.95%	2,466 $547,000
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $4,967 - $6,054	22 Added 1.5%	1,486 $359,000
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $431,492 - $548,262	-1,884 Reduced 56.27%	1,464 $384,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $125,697 - $141,764	-560 Reduced 14.33%	3,348 $755,000
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $51,679 - $57,509	-224 Reduced 5.42%	3,908 $951,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $370,785 - $410,185	-1,691 Reduced 29.04%	4,132 $999,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $731,082 - $836,657	3,676 Added 171.22%	5,823 $1.31 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $2.19 Million - $2.57 Million	-10,322 Reduced 82.78%	2,147 $457,000
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $2.91 Million - $3.23 Million	12,469 New	12,469 $3.04 Million
Q2 2020 Aug 17, 2020	SELL	$197.81 - $242.74 $1.18 Million - $1.44 Million	-5,947 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $1.08 Million - $1.44 Million	5,947 New	5,947 $1.21 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $537,356 - $690,688	-2,840 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $749,021 - $897,483	-4,302 Reduced 60.24%	2,840 $550,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $1.19 Million - $1.4 Million	7,142 New	7,142 $1.32 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Amgen Inc Transaction History